{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:27:35Z","timestamp":1790782055035,"version":"4.1.0"},"reference-count":260,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.jgyn.2007.04.002","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T05:50:19Z","timestamp":1330321819000},"page":"423-446","source":"Crossref","is-referenced-by-count":9,"title":["Le syndrome des\u00a0ovaires polykystiques (SOPK)"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6543","key":"10.1016\/j.jgyn.2007.04.002_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.84.6.1897","article-title":"Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women","volume":"84","author":"Carmina","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.jgyn.2007.04.002_bib3","first-page":"863","article-title":"Polycystic ovarian dystrophies. Diagnostic criteria and treatment","volume":"24","author":"Emperauger","year":"1995","journal-title":"Presse Med."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria","volume":"91","author":"Franks","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.fertnstert.2005.11.003","article-title":"How many of the items in the polycystic ovary syndrome can be validated statistically?","volume":"85","author":"McDonough","year":"2006","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.fertnstert.2005.11.001","article-title":"How many of the items in the polycystic ovary syndrome can be validated statistically?","volume":"85","author":"Dewailly","year":"2006","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib9","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib10","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation with polycystic ovaries but not overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1472-6483(10)62107-4","article-title":"Surgical treatment of polycystic ovary syndrome associated with infertility","volume":"9","author":"Gomel","year":"2004","journal-title":"Reprod. Biomed. Online"},{"issue":"12","key":"10.1016\/j.jgyn.2007.04.002_bib12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09513590500216776","article-title":"Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome","volume":"21","author":"Charnvises","year":"2005","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2005.05.006","article-title":"Insulin resistance in adolescents with menstrual irregularities","volume":"18","author":"Fernandes","year":"2005","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2265.2001.01399.x","article-title":"Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect","volume":"55","author":"Ibanez","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib16","first-page":"123","article-title":"Physiopathology of polycystic ovary syndrome","volume":"60","author":"Dewailly","year":"1999","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/me.13.6.946","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.jgyn.2007.04.002_bib18","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jc.86.12.5925","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2004-0178","article-title":"Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome","volume":"19","author":"Nelson-Degrave","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1210\/endo-128-1-509","article-title":"A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo","volume":"128","author":"Haisenleder","year":"1991","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib21","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/jc.85.11.4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.1991.tb00235.x","article-title":"Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?","volume":"19","author":"Pache","year":"1991","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum. Reprod. Update"},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib24","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1210\/jc.83.11.3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/713603120","article-title":"Insulin: does it induce follicular arrest in the rat ovary?","volume":"16","author":"Kuscu","year":"2002","journal-title":"Gynecol. Endocrinol."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib26","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1210\/jc.2005-0695","article-title":"Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis","volume":"90","author":"Welt","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.jgyn.2007.04.002_bib27","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1210\/jc.86.9.4206","article-title":"Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles","volume":"86","author":"Fujiwara","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jgyn.2007.04.002_bib28","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1210\/jc.2005-2204","article-title":"Genetic susceptibility for polycystic ovary syndrome on chromosome 19: advances in the genetic dissection of complex reproductive traits","volume":"90","author":"Florez","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.jgyn.2007.04.002_bib29","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1073\/pnas.0602025103","article-title":"Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome","volume":"103","author":"Sam","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1210\/jc.2005-1707","article-title":"Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome","volume":"91","author":"Leibel","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2005.10.059","article-title":"Endothelial dysfunction in PCOS: role of obesity and adipose hormones","volume":"119","author":"Carmina","year":"2006","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/eje.1.02027","article-title":"Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness","volume":"153","author":"Lystedt","year":"2005","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.jgyn.2007.04.002_bib34","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1210\/jc.83.9.3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib35","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1210\/jc.85.7.2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib36","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.84.11.4006","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1067\/mob.2002.126650","article-title":"Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations","volume":"187","author":"Kauffman","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1479-828X.2001.tb01210.x","article-title":"The impact of ethnicity on the presentation of polycystic ovarian syndrome","volume":"41","author":"Williamson","year":"2001","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"Suppl 5","key":"10.1016\/j.jgyn.2007.04.002_bib39","first-page":"1303","article-title":"Family history as a risk factor for the polycystic ovary syndrome","volume":"13","author":"Azziz","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.jgyn.2007.04.002_bib40","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"25","key":"10.1016\/j.jgyn.2007.04.002_bib41","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil. Steril."},{"issue":"29","key":"10.1016\/j.jgyn.2007.04.002_bib44","doi-asserted-by":"crossref","first-page":"26380","DOI":"10.1074\/jbc.M300688200","article-title":"The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis","volume":"278","author":"Wood","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency","volume":"34","author":"Draper","year":"2003","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/BF03345266","article-title":"Genetic and environmental aspect of polycystic ovary syndrome","volume":"26","author":"Carmina","year":"2003","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00129785-200404020-00004","article-title":"Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy","volume":"4","author":"Roldan","year":"2004","journal-title":"Am. J. Pharmacogenomics"},{"issue":"1-2","key":"10.1016\/j.jgyn.2007.04.002_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2005.10.017","article-title":"Genomic variants in polycystic ovary syndrome","volume":"366","author":"Luque-Ramirez","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jc.85.3.1206","article-title":"Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys","volume":"85","author":"Eisner","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/oby.2003.42","article-title":"Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation","volume":"11","author":"Eisner","year":"2003","journal-title":"Obes. Res."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0015-0282(01)02947-8","article-title":"Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess","volume":"77","author":"Eisner","year":"2002","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome - a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib53","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","article-title":"Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies","volume":"91","author":"Xita","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib54","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","article-title":"Clinical management of metabolic syndrome: report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association conference on scientific issues related to management","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jgyn.2007.04.002_bib57","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib59","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib60","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/dei009","article-title":"Birth weight in offspring of mothers with polycystic ovarian syndrome","volume":"20","author":"Sir-Petermann","year":"2005","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib61","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib62","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2265.2004.01981.x","article-title":"Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries","volume":"60","author":"Kaushal","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"10.1016\/j.jgyn.2007.04.002_bib64","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dei070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jgyn.2007.04.002_bib65","first-page":"103","article-title":"Metabolic syndrome and polycystic ovary syndrome","author":"Bruzeau","year":"2005","journal-title":"Journ. Annu. Diabetol. Hotel Dieu"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib66","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/jc.86.4.1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic ovary syndrome: a changing perspective","volume":"31","author":"Franks","year":"1989","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib69","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib73","first-page":"31","article-title":"The diabetes and obesity epidemic among the Pima Indians","volume":"97","author":"Krosnick","year":"2000","journal-title":"N. J. Med."},{"issue":"9","key":"10.1016\/j.jgyn.2007.04.002_bib74","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib75","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jgyn.2007.04.002_bib76","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/j.0001-6349.2005.00627.x","article-title":"Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome","volume":"84","author":"Trolle","year":"2005","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib77","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/er.18.6.774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jgyn.2007.04.002_bib79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199603213341207","article-title":"Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance","volume":"334","author":"Polonsky","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib80","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diabetes.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib81","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00125-002-0776-y","article-title":"Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance","volume":"45","author":"Ehrmann","year":"2002","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib82","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1152\/ajpendo.00475.2003","article-title":"Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome","volume":"287","author":"Ehrmann","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib83","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jc.76.5.1241","article-title":"Defects in beta-cell function in functional ovarian hyperandrogenism","volume":"76","author":"O'Meara","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib84","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.81.3.942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib85","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2000.01123.x","article-title":"The prevalence of polycystic ovaries in women with a history of gestational diabetes","volume":"53","author":"Kousta","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib86","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/jc.75.2.508","article-title":"Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance","volume":"75","author":"Zimmermann","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib87","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil. Steril."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib88","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib89","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jc.87.2.742","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib90","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/jc.2002-020386","article-title":"Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome","volume":"88","author":"Paradisi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.jgyn.2007.04.002_bib91","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib92","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib93","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jc.87.8.3871","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib94","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib95","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1479-828X.2006.00541.x","article-title":"Do women with polycystic ovary syndrome really have predisposition to atherosclerosis?","volume":"46","author":"Topcu","year":"2006","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib96","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1210\/jc.2006-0216","article-title":"Cardiopulmonary impairment in young women with polycystic ovary syndrome","volume":"91","author":"Orio","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib97","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1210\/jc.82.7.2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib98","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib99","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.metabol.2005.09.008","article-title":"Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome","volume":"55","author":"Glueck","year":"2006","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib101","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/humrep\/deh700","article-title":"Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study","volume":"20","author":"Kilicdag","year":"2005","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib102","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.contraception.2005.09.011","article-title":"Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome","volume":"73","author":"Cagnacci","year":"2006","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib103","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib104","first-page":"27","article-title":"Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence","volume":"56","author":"Talbott","year":"2004","journal-title":"Minerva Ginecol."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum. Fertil. (Camb.)"},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1389-9457(02)00033-3","article-title":"The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome","volume":"3","author":"Gopal","year":"2002","journal-title":"Sleep Med."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib108","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/jc.86.2.517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib109","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1210\/jc.86.3.1175","article-title":"Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome","volume":"86","author":"Fogel","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jc.2005-1084","article-title":"Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome","volume":"91","author":"Tasali","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib111","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum. Reprod. Update"},{"issue":"9371","key":"10.1016\/j.jgyn.2007.04.002_bib112","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib113","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/humrep\/dei420","article-title":"The association between polycystic ovaries and endometrial cancer","volume":"21","author":"Pillay","year":"2006","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib114","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib116","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejogrb.2004.06.024","article-title":"PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?","volume":"118","author":"Doi","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib117","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.87.2.524","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib118","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2004-1658","article-title":"Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome","volume":"89","author":"Norman","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib119","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00001703-200406000-00007","article-title":"Should we continue or stop insulin sensitizing drugs during pregnancy?","volume":"16","author":"Norman","year":"2004","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/humrep\/15.3.612","article-title":"Polycystic ovaries and recurrent miscarriage--a reappraisal","volume":"15","author":"Rai","year":"2000","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib121","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2004.11.005","article-title":"Evidence-based care of recurrent miscarriage","volume":"19","author":"Porter","year":"2005","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib122","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/humrep\/13.2.478","article-title":"Recurrent miscarriage: principles of management","volume":"13","author":"Li","year":"1998","journal-title":"Hum. Reprod."},{"issue":"8724","key":"10.1016\/j.jgyn.2007.04.002_bib123","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib124","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","article-title":"Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin","volume":"99","author":"Hamilton-Fairley","year":"1992","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/j.1600-0412.2000.079001043.x","article-title":"Obesity is a risk factor for early pregnancy loss after IVF or ICSI","volume":"79","author":"Fedorcsak","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib126","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/humrep\/deh485","article-title":"Impact of overweight and underweight on assisted reproduction treatment","volume":"19","author":"Fedorcsak","year":"2004","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ecl.2005.09.005","article-title":"Fertility in polycystic ovary syndrome","volume":"35","author":"Patel","year":"2006","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"12","key":"10.1016\/j.jgyn.2007.04.002_bib128","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib129","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/jc.2003-030975","article-title":"Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy","volume":"89","author":"Jakubowicz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jgyn.2007.04.002_bib130","series-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","author":"Boomsma","year":"2006"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib132","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/jc.84.4.1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib133","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","article-title":"Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome","volume":"88","author":"Moran","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"26","key":"10.1016\/j.jgyn.2007.04.002_bib134","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib136","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib137","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib138","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jgyn.2007.04.002_bib139","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1993.tb43875.x","article-title":"Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome","volume":"687","author":"Golland","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib141","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/09513590009167658","article-title":"Treatment of hirsutism with lowest-dose flutamide (62.5\u00a0mg\/day)","volume":"14","author":"Muderris","year":"2000","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib142","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jc.85.1.89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib143","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib144","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib145","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1210\/jc.83.7.2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib146","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.84.3.946","article-title":"Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level","volume":"84","author":"Azziz","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib147","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/endo-112-4-1460","article-title":"Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes","volume":"112","author":"Liang","year":"1983","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib148","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/eje.0.1410361","article-title":"Comparison of finasteride versus flutamide in the treatment of hirsutism","volume":"141","author":"Falsetti","year":"1999","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib149","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","article-title":"A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome","volume":"81","author":"Stamets","year":"2004","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2005.08.045","article-title":"Role of diet in the treatment of polycystic ovary syndrome","volume":"85","author":"Douglas","year":"2006","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib151","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib152","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib153","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2005-1994","article-title":"Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial","volume":"91","author":"Eisenhardt","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib154","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajog.2005.11.009","article-title":"Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin","volume":"194","author":"Banaszewska","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib155","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/jc.80.7.2057","article-title":"Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib156","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1071-5576(02)00149-1","article-title":"Troglitazone: a possible modulator of ovarian steroidogenesis","volume":"9","author":"Mitwally","year":"2002","journal-title":"J. Soc. Gynecol. Investig."},{"issue":"9","key":"10.1016\/j.jgyn.2007.04.002_bib157","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1210\/jc.81.9.3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib158","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/humrep\/dei505","article-title":"Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study","volume":"21","author":"Rautio","year":"2006","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib159","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome","volume":"79","author":"Ghazeeri","year":"2003","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2003.08.024","article-title":"Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome","volume":"81","author":"Belli","year":"2004","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib161","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib162","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib163","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590500231627","article-title":"The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome","volume":"21","author":"Yilmaz","year":"2005","journal-title":"Gynecol. Endocrinol."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib164","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1210\/jc.83.8.2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.20.4.535","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib166","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0950-3552(98)80051-5","article-title":"Adverse effects of luteinizing hormone on fertility: fact or fantasy","volume":"12","author":"Homburg","year":"1998","journal-title":"Baillieres Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib167","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/09513590400012093","article-title":"The impact of insulin resistance on the outcome of laparoscopic ovarian electrocautery in infertile women with the polycystic ovary syndrome","volume":"19","author":"Dale","year":"2004","journal-title":"Gynecol. Endocrinol."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib168","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1210\/jc.81.11.3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib169","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib171","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jgyn.2007.04.002_bib172","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1477-7827-1-109","article-title":"The management of infertility associated with polycystic ovary syndrome","volume":"1","author":"Homburg","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib173","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fertnstert.2005.06.052","article-title":"Higher-order multiple pregnancy associated with metformin in women with polycystic ovary syndrome: two cases and review of the literature","volume":"85","author":"Boothroyd","year":"2006","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib174","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.OGX.0000109224.52893.B8","article-title":"Metformin in obstetric and gynecologic practice: a review","volume":"59","author":"McCarthy","year":"2004","journal-title":"Obstet. Gynecol. Surv."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1464-5491.2000.00314.x","article-title":"Oral hypoglycaemic agents in 118 diabetic pregnancies","volume":"17","author":"Hellmuth","year":"2000","journal-title":"Diabet. Med."},{"issue":"7421","key":"10.1016\/j.jgyn.2007.04.002_bib176","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib177","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome","volume":"19","author":"Kashyap","year":"2004","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib178","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum. Reprod."},{"issue":"7556","key":"10.1016\/j.jgyn.2007.04.002_bib179","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib180","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib181","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.fertnstert.2005.07.1312","article-title":"A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome","volume":"85","author":"Rouzi","year":"2006","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib182","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/jc.2004-0689","article-title":"Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial","volume":"89","author":"Palomba","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib183","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajog.2004.05.030","article-title":"Does metformin induce ovulation in normoandrogenic anovulatory women?","volume":"191","author":"Carmina","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib184","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil. Steril."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib185","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome","volume":"90","author":"Palomba","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib186","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1590\/S0100-879X2004001100007","article-title":"Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome","volume":"37","author":"Meenakumari","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jgyn.2007.04.002_bib187","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.105.041186","article-title":"The Beneficial Effects of Insulin and Metformin on in vitro Developmental Potential of Porcine Oocytes and Embryos","author":"Lee","year":"2005","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib188","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/humrep\/dei351","article-title":"Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2006","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib189","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib190","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.fertnstert.2005.09.047","article-title":"Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin","volume":"85","author":"Thatcher","year":"2006","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib191","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0015-0282(01)03266-6","article-title":"Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome","volume":"77","author":"Heard","year":"2002","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib192","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/107602960401000404","article-title":"Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin","volume":"10","author":"Glueck","year":"2004","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib193","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.04.021","article-title":"Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jgyn.2007.04.002_bib194","series-title":"A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination","author":"Palomba","year":"2005"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00404-002-0447-8","article-title":"The effect of metformin treatment to ovarian response in cases with PCOS","volume":"269","author":"Tasdemir","year":"2004","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib196","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"De Leo","year":"1999","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib197","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/humrep\/deh248","article-title":"Metformin treatment before IVF\/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study","volume":"19","author":"Kjotrod","year":"2004","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib198","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.fertnstert.2005.03.043","article-title":"Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial","volume":"84","author":"Onalan","year":"2005","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib199","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome","volume":"21","author":"Costello","year":"2006","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib201","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0015-0282(16)46033-4","article-title":"A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test","volume":"37","author":"Gysler","year":"1982","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib202","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)36736-X","article-title":"Further clinical experience with clomiphene citrate","volume":"19","author":"Macgregor","year":"1968","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil. Steril."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib204","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1210\/jc.83.7.2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6655","key":"10.1016\/j.jgyn.2007.04.002_bib205","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib206","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1472-6483(10)61273-4","article-title":"Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy","volume":"9","author":"Lopez","year":"2004","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib207","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oxfordjournals.humrep.a135937","article-title":"Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation","volume":"10","author":"Agarwal","year":"1995","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib208","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0028-2243(81)90034-4","article-title":"Induction of ovulation by combined clomiphene citrate and dexamethasone treatment in clomiphene citrate nonresponders","volume":"11","author":"Diamant","year":"1981","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib209","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(16)47896-9","article-title":"A randomized study of dexamethasone in ovulation induction with clomiphene citrate","volume":"41","author":"Daly","year":"1984","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib211","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0015-0282(01)03280-0","article-title":"Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders","volume":"77","author":"Mitwally","year":"2002","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.fertnstert.2005.08.016","article-title":"Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone\/follicle-stimulating hormone ratio","volume":"85","author":"Elnashar","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jgyn.2007.04.002_bib213","first-page":"465","article-title":"Stein","volume":"38","year":"1939","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib214","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1074-3804(05)60054-0","article-title":"Fertility after ovarian drilling by transvaginal fertiloscopy for treatment of polycystic ovary syndrome","volume":"11","author":"Fernandez","year":"2004","journal-title":"J. Am. Assoc. Gynecol. Laparosc."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib215","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0015-0282(00)01746-5","article-title":"Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery","volume":"75","author":"Fernandez","year":"2001","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib216","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1297-9589(03)00041-9","article-title":"Ovarian drilling for surgical approach of polycystic ovary syndrome","volume":"31","author":"Fernandez","year":"2003","journal-title":"Gynecol. Obstet. Fertil."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib217","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1447-0756.2005.00255.x","article-title":"Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: how many punctures per ovary are needed to improve the reproductive outcome?","volume":"31","author":"Malkawi","year":"2005","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib218","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/humrep\/deg307","article-title":"A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy","volume":"18","author":"Amer","year":"2003","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib219","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2004.07.023","article-title":"Laparoscopic ovarian drilling in polycystic ovary syndrome","volume":"119","author":"Api","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib220","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-0528.2005.00684.x","article-title":"Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome","volume":"112","author":"Kandil","year":"2005","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib221","first-page":"CR29","article-title":"Hormone profiles and clinical outcome after laparoscopic ovarian drilling in women with polycystic ovary syndrome","volume":"11","author":"Kucuk","year":"2005","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib222","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/humrep\/deh343","article-title":"Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success","volume":"19","author":"Amer","year":"2004","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib223","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/00016349409006253","article-title":"Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results","volume":"73","author":"Gjonnaess","year":"1994","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib224","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/humrep\/deh712","article-title":"Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome","volume":"20","author":"van Wely","year":"2005","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0950-351X(96)80141-8","article-title":"Surgical ovulation induction: the role of ovarian diathermy in polycystic ovary syndrome","volume":"10","author":"Donesky","year":"1996","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib226","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001122","article-title":"Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","author":"Farquhar","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7433","key":"10.1016\/j.jgyn.2007.04.002_bib227","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bmj.328.7433.192","article-title":"Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial","volume":"328","author":"Bayram","year":"2004","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib228","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/humrep\/deh319","article-title":"An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome","volume":"19","author":"van Wely","year":"2004","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib229","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2265.1990.tb03896.x","article-title":"Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease","volume":"33","author":"Abdel Gadir","year":"1990","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0015-0282(98)00006-5","article-title":"Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome","volume":"69","author":"Gjonnaess","year":"1998","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib231","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/humrep\/16.1.91","article-title":"Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study","volume":"16","author":"Tozer","year":"2001","journal-title":"Hum. Reprod."},{"issue":"7","key":"10.1016\/j.jgyn.2007.04.002_bib232","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib233","first-page":"85","article-title":"Gonadotropin therapy: new trends and insights","volume":"33","author":"Insler","year":"1988","journal-title":"Int. J. Fertil."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib234","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/jc.83.2.423","article-title":"Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome","volume":"83","author":"Van Der Meer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib235","first-page":"39","article-title":"Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation","volume":"29","author":"Seibel","year":"1984","journal-title":"Int. J. Fertil."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib236","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2265.1987.tb00778.x","article-title":"Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome","volume":"26","author":"Polson","year":"1987","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib237","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0015-0282(16)57964-3","article-title":"Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome","volume":"64","author":"Schoot","year":"1995","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib238","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/HUMREP\/11.3.478","article-title":"Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen","volume":"11","author":"van Dessel","year":"1996","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib239","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0950-3552(05)80313-X","article-title":"Common problems in induction of ovulation","volume":"4","author":"Hamilton-Fairley","year":"1990","journal-title":"Baillieres Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib240","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0015-0282(16)57473-1","article-title":"A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome","volume":"63","author":"Homburg","year":"1995","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.jgyn.2007.04.002_bib241","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/humrep\/13.10.2688","article-title":"A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women","volume":"13","author":"Hedon","year":"1998","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib242","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/5.5.493","article-title":"Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements","volume":"5","author":"Homburg","year":"1999","journal-title":"Hum. Reprod. Update"},{"issue":"11","key":"10.1016\/j.jgyn.2007.04.002_bib243","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1210\/jc.82.11.3597","article-title":"Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens","volume":"82","author":"van Santbrink","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jgyn.2007.04.002_bib244","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Maitre","year":"2003","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib245","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","article-title":"In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome","volume":"60","author":"Homburg","year":"1993","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib246","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0015-0282(16)55794-X","article-title":"Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome","volume":"59","author":"Homburg","year":"1993","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib247","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.humrep.a137035","article-title":"Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries","volume":"5","author":"Homburg","year":"1990","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib248","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(16)58569-0","article-title":"The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study","volume":"66","author":"van der Meer","year":"1996","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib249","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/oxfordjournals.humrep.a138123","article-title":"The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome","volume":"8","author":"Scheele","year":"1993","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jgyn.2007.04.002_bib250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0015-0282(02)04696-4","article-title":"Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome","volume":"79","author":"Elkind-Hirsch","year":"2003","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib251","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.jgyn.2007.04.002_bib252","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0029-7844(02)02193-2","article-title":"A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries","volume":"100","author":"Child","year":"2002","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.jgyn.2007.04.002_bib253","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","article-title":"Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program","volume":"55","author":"Cha","year":"1991","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib254","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1472-6483(10)60511-1","article-title":"In-vitro maturation of human oocytes","volume":"8","author":"Chian","year":"2004","journal-title":"Reprod. Biomed. Online"},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib255","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.fertnstert.2004.11.044","article-title":"Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer","volume":"83","author":"Cha","year":"2005","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib256","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0015-0282(00)00422-2","article-title":"Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome","volume":"73","author":"Cha","year":"2000","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jgyn.2007.04.002_bib257","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/humrep\/deh768","article-title":"Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients","volume":"20","author":"Soderstrom-Anttila","year":"2005","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib258","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1472-6483(10)61666-5","article-title":"Strategies in human in-vitro maturation and their clinical outcome","volume":"10","author":"Mikkelsen","year":"2005","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.jgyn.2007.04.002_bib259","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.humrep.a138029","article-title":"A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization","volume":"8","author":"MacDougall","year":"1993","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.jgyn.2007.04.002_bib260","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(01)02853-9","article-title":"In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome","volume":"76","author":"Child","year":"2001","journal-title":"Fertil. Steril."}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231507001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231507001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T15:13:34Z","timestamp":1561389214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231507001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":260,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0368231507001676"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2007.04.002","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}